1Department of Cardiology, Istanbul Mehmet Akif Ersoy Thoracic-Cardiovascular Surgery Training and Research Hospital, Istanbul, Turkey.
Clin Appl Thromb Hemost. 2014 May;20(4):378-84. doi: 10.1177/1076029612465669. Epub 2012 Nov 8.
We sought to determine the prognostic value of neutrophil to lymphocyte ratio (NLR) in non-ST elevation myocardial infarction (NSTEMI) and unstable angina pectoris (UAP). A total of 308 (mean age 59.22 ± 11.93) patients with NSTEMI and UAP were prospectively evaluated. The study population was divided into tertiles based on admission NLR values. The patients were followed for clinical outcomes for up to 3 years after discharge. In the Kaplan-Meier survival analysis, 3-year mortality was 21.6% in patients with high NLR versus 3% in the low-NLR group (P < .001). In a receiver-operating characteristic curve analysis, an NLR value of 3.04 was identified as an effective cut point in NSTEMI and UAP of a 3-year cardiovascular mortality (area under curve [AUC] = 0.86, 95% confidence interval [CI] 0.8-0.92). An NLR value >3.04 yielded a sensitivity of 79% and specificity of 71%. Admission NLR is the strong and independent predictor of a 3-year cardiovascular mortality in patients with NSTEMI and UAP.
我们旨在确定中性粒细胞与淋巴细胞比值(NLR)在非 ST 段抬高型心肌梗死(NSTEMI)和不稳定型心绞痛(UAP)中的预后价值。前瞻性评估了 308 名(平均年龄 59.22 ± 11.93 岁)患有 NSTEMI 和 UAP 的患者。根据入院时 NLR 值将研究人群分为三分位。患者在出院后最长 3 年的时间内随访临床结局。在 Kaplan-Meier 生存分析中,高 NLR 组患者 3 年死亡率为 21.6%,低 NLR 组为 3%(P<.001)。在受试者工作特征曲线分析中,NLR 值为 3.04 被确定为 NSTEMI 和 UAP 3 年心血管死亡率的有效切点(曲线下面积 [AUC] = 0.86,95%置信区间 [CI] 0.8-0.92)。NLR 值>3.04 的敏感性为 79%,特异性为 71%。入院时 NLR 是 NSTEMI 和 UAP 患者 3 年心血管死亡率的强有力且独立的预测因子。